-
Something wrong with this record ?
Aktuálne postupy u pacientov so zlomeninami proximálneho femuru užívajúcich protidoštičkovú a antikoagulačnú liečbu
[Current Management of Patients with Proximal Femur Fractures Receiving Antiplatelet and Anticoagulant Therapy]
B. Šteňo, A. Bátorová, D. Jankovičová, T. Prigancová, J. Hložník, A. Švec, I. Chandoga
Language Slovak Country Czech Republic
Document type Journal Article, Review, English Abstract
PubMed
39496190
DOI
10.55095/achot2024/041
- MeSH
- Anticoagulants * adverse effects administration & dosage therapeutic use MeSH
- Aspirin adverse effects therapeutic use administration & dosage MeSH
- Femoral Fractures surgery MeSH
- Proximal Femoral Fractures MeSH
- Platelet Aggregation Inhibitors * adverse effects therapeutic use MeSH
- Humans MeSH
- Warfarin adverse effects therapeutic use administration & dosage MeSH
- Check Tag
- Humans MeSH
- Publication type
- English Abstract MeSH
- Journal Article MeSH
- Review MeSH
Proximal femur fractures (PFF) pose a major challenge in elderly patients with severe comorbidities and receiving antithrombotic therapy since according to the latest guidelines the surgery should be performed as soon as possible, preferably within 24 hours, to reduce mortality and morbidity. This review outlines the practical approach to surgical management of PFF that relies on increasing evidence of safety of early surgery in patients with PFF receiving antiplatelet and anticoagulant therapy. We have also used information from the existing evidence-based guidelines for elective/planned surgery in patients with antithrombotic therapy. The practical approach can be summarised as follows: • Antiplatelet therapy - discontinuation of acetylsalicylic acid (ASA) and clopidogrel in monotherapy or in combination is not necessary prior to surgery. In case of bleeding, antifibrinolytic therapy is recommended as well as administration of platelet concentrate which is rarely needed. • In patients taking warfarin, reversal of its effects is recommended by early administration of vitamin K to allow surgery to be performed within 24 hours. Prothrombin complex concentrate (PCC) as a second-line drug is reserved for extreme cases only. Warfarin therapy is resumed 24 hours after surgery. • Direct oral anticoagulants must be discontinued 24-48 hours prior to surgery, possibly longer depending on the type of drug, time of administration of the last dose, and renal function. In extreme cases, an antidote (idarucizumab, off-label andexanet) can be administered prior to surgery, or PCC in case they are unavailable. Anticoagulation therapy is resumed in 24-48 hours. • Neuraxial anaesthesia is possible when ASA is taken by the patient and in case of effective warfarin reversal. • In early surgery and rapid restart of anticoagulant therapy, bridging therapy with LMWH is not indicated except for in cases with extreme risk of thrombosis. Key words: proximal femur fracture, antiplatelet therapy, anticoagulant therapy, perioperative management.
Current Management of Patients with Proximal Femur Fractures Receiving Antiplatelet and Anticoagulant Therapy
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24022782
- 003
- CZ-PrNML
- 005
- 20250218134132.0
- 007
- ta
- 008
- 241205s2024 xr f 000 0|slo||
- 009
- AR
- 024 7_
- $a 10.55095/ACHOT2024/041 $2 doi
- 035 __
- $a (PubMed)39496190
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a slo $b eng
- 044 __
- $a xr
- 100 1_
- $a Šteňo, Boris $u II. ortopedicko-traumatologická klinika Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava $7 xx0112158
- 245 10
- $a Aktuálne postupy u pacientov so zlomeninami proximálneho femuru užívajúcich protidoštičkovú a antikoagulačnú liečbu / $c B. Šteňo, A. Bátorová, D. Jankovičová, T. Prigancová, J. Hložník, A. Švec, I. Chandoga
- 246 31
- $a [Current Management of Patients with Proximal Femur Fractures Receiving Antiplatelet and Anticoagulant Therapy]
- 520 9_
- $a Proximal femur fractures (PFF) pose a major challenge in elderly patients with severe comorbidities and receiving antithrombotic therapy since according to the latest guidelines the surgery should be performed as soon as possible, preferably within 24 hours, to reduce mortality and morbidity. This review outlines the practical approach to surgical management of PFF that relies on increasing evidence of safety of early surgery in patients with PFF receiving antiplatelet and anticoagulant therapy. We have also used information from the existing evidence-based guidelines for elective/planned surgery in patients with antithrombotic therapy. The practical approach can be summarised as follows: • Antiplatelet therapy - discontinuation of acetylsalicylic acid (ASA) and clopidogrel in monotherapy or in combination is not necessary prior to surgery. In case of bleeding, antifibrinolytic therapy is recommended as well as administration of platelet concentrate which is rarely needed. • In patients taking warfarin, reversal of its effects is recommended by early administration of vitamin K to allow surgery to be performed within 24 hours. Prothrombin complex concentrate (PCC) as a second-line drug is reserved for extreme cases only. Warfarin therapy is resumed 24 hours after surgery. • Direct oral anticoagulants must be discontinued 24-48 hours prior to surgery, possibly longer depending on the type of drug, time of administration of the last dose, and renal function. In extreme cases, an antidote (idarucizumab, off-label andexanet) can be administered prior to surgery, or PCC in case they are unavailable. Anticoagulation therapy is resumed in 24-48 hours. • Neuraxial anaesthesia is possible when ASA is taken by the patient and in case of effective warfarin reversal. • In early surgery and rapid restart of anticoagulant therapy, bridging therapy with LMWH is not indicated except for in cases with extreme risk of thrombosis. Key words: proximal femur fracture, antiplatelet therapy, anticoagulant therapy, perioperative management.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a antikoagulancia $x škodlivé účinky $x aplikace a dávkování $x terapeutické užití $7 D000925
- 650 12
- $a inhibitory agregace trombocytů $x škodlivé účinky $x terapeutické užití $7 D010975
- 650 _2
- $a fraktury femuru $x chirurgie $7 D005264
- 650 _2
- $a warfarin $x škodlivé účinky $x terapeutické užití $x aplikace a dávkování $7 D014859
- 650 _2
- $a Aspirin $x škodlivé účinky $x terapeutické užití $x aplikace a dávkování $7 D001241
- 650 _2
- $a fraktury proximálního femuru $7 D000092526
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a anglický abstrakt $7 D004740
- 700 1_
- $a Bátorová, Angelika $u Klinika hematológie a transfuziológie Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava $7 xx0103090
- 700 1_
- $a Jankovičová, Denisa $u Klinika hematológie a transfuziológie Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava $7 xx0259636
- 700 1_
- $a Prigancová, Tatiana $u Klinika hematológie a transfuziológie Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava $7 xx0230129
- 700 1_
- $a Hložník, J $u Oddelenie anesteziológie a intenzívnej medicíny, Nemocnica Sv. Cyrila a Metoda, Univerzitná nemocnica Bratislava
- 700 1_
- $a Švec, Andrey $u I. ortopedicko-traumatologická klinika Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava $7 xx0099792
- 700 1_
- $a Chandoga, Ilja, $u II. ortopedicko-traumatologická klinika Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava $d 1977- $7 xx0262786
- 773 0_
- $w MED00011021 $t Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca $x 0001-5415 $g Roč. 91, č. 5 (2024), s. 257-263
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39496190 $y Pubmed
- 910 __
- $a ABA008 $b A 8 $c 507 $y p $z 0
- 990 __
- $a 20241205 $b ABA008
- 991 __
- $a 20250218134128 $b ABA008
- 999 __
- $a ok $b bmc $g 2270201 $s 1234787
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 91 $c 5 $d 257-263 $e - $i 0001-5415 $m Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca $n Acta Chir Orthop Traumatol Cech $x MED00011021
- LZP __
- $b NLK138 $a Pubmed-20241205